Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | SI | P14410 | 1/20 | 0.43 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2550182 | 0.79 | ALDH1A1 (0.36) | MEN1KMT2AALDH1A1LMNAMAPT | |
| SCHEMBL3453844 | 0.79 | ALDH1A1 (0.34) | MEN1KMT2AALDH1A1 | |
| SCHEMBL612528 | 0.79 | ALDH1A1 (0.37) | MEN1KMT2AALDH1A1MAPT | |
| Hydrochloric Acid SCHEMBL28514951 | 0.77 | ALDH1A1 (0.35) | MEN1KMT2AALDH1A1 | |
| Acetic Acid SCHEMBL28451523 | 0.75 | ALDH1A1 (0.34) | MEN1KMT2AALDH1A1LMNA | |
| SCHEMBL7716538 | 0.74 | MGAM (0.50) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL3138795 | 0.73 | ALDH1A1 (0.39) | MEN1KMT2AALDH1A1 | |
| SCHEMBL3999886 | 0.73 | ALDH1A1 (0.38) | ALDH1A1LMNAMAPT | |
| Sulfur Dioxide SCHEMBL28461053 | 0.73 | ALDH1A1 (0.33) | MEN1KMT2AALDH1A1 | |
| SCHEMBL1489101 | 0.73 | ALDH1A1 (0.44) | MEN1KMT2AALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210085633-A1 | RIVASTIGMINE-CONTAINING TRANSDERMAL ABSORPTION PREPARATION | TEIKOKU SEIYAKU CO., LTD. (JP) | 2021-03-25 | — | — | US | disclosed |
| EP-3656383-A1 | RIVASTIGMINE-CONTAINING PERCUTANEOUS ABSORPTION-TYPE PREPARATION | Teikoku Seiyaku Co., Ltd. (JP) | 2020-05-27 | — | — | EP | disclosed |
| US-20040028724-A1 | Pharmaceutical preparation of percutaneous absorption type | HISAMITSU PHARMACEUTICAL CO., INC. (JP) | 2004-02-12 | — | — | US | disclosed |
| EP-1340496-A1 | PHARMACEUTICAL PREPARATION OF PERCUTANEOUS ABSORPTION TYPE | HISAMITSU PHARMACEUTICAL CO. INC. (JP) | 2003-09-03 | — | — | EP | disclosed |